Related Experiment Video
Updated: Aug 30, 2025
New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation
Published on: June 27, 2025
Liver Transplantation and Budd-Chiari Syndrome: When the Cause Becomes the Solution
Nikolaos Garmpis1, Christos Damaskos2, Dionysios Prevezanos3
1Second Department of Propedeutic Surgery, Laiko General Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Insights
Budd-Chiari syndrome, a rare condition causing liver vein obstruction, presents a paradox where liver transplantation can be both a cause and a cure. High clinical suspicion is vital for managing this life-threatening disorder.
Area of Science:
- Hepatology
- Vascular Surgery
- Transplantation Medicine
Background:
- Budd-Chiari syndrome involves obstruction of hepatic venous outflow, affecting 0.1-10 per million annually.
- Classifications include acute/chronic and primary/secondary, with iatrogenic causes like liver transplantation.
- This syndrome is a rare but serious complication following liver transplantation.
Discussion:
- Liver transplantation, the definitive treatment for Budd-Chiari syndrome, can paradoxically cause it.
- This creates a vicious cycle where the treatment becomes a potential cause.
- Understanding this dual role is crucial for patient management.
Key Insights:
- Liver transplantation is both a cause and treatment for Budd-Chiari syndrome.
- Budd-Chiari syndrome is a complication and cause related to liver transplantation.
- Clinical vigilance is essential for accurate diagnosis and effective management.
Outlook:
- Further research into preventing iatrogenic Budd-Chiari syndrome post-transplant.
- Developing strategies to mitigate the risk of Budd-Chiari syndrome recurrence after transplantation.
- Improving diagnostic criteria and early detection methods for Budd-Chiari syndrome.
Abstract:
Budd-Chiari syndrome consists a rare medical entity which has an estimated incidence of 0.1 to 10 people per million every year. It is defined by the obstruction of the flow in the inferior vena cava or the hepatic veins. Various classifications have been proposed. So, it can be acute or chronic and primary or secondary. Iatrogenic, a subtype of secondary Budd-Chiari syndrome, is caused by various medical interventions, including liver transplantation. On the other hand, liver transplantation is the ultimate therapeutic management of Budd-Chiari syndrome. Finally, a medical paradox and a vicious circle has been created. Liver transplantation can potentially be both the cause and treatment of Budd-Chiari syndrome. Budd-Chiari syndrome is simultaneously the cause and complication of liver transplantation. Our aim is to describe this double role of liver transplantation in Budd-Chiari syndrome and to acknowledge that a high degree of clinical suspicion is necessary for the proper recognition and management of this life-threatening condition.
Related Concept Videos
01:28Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
01:26Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...